Doximity launches Doximity Dialer Video- a free telehealth app for providers

Doximity | May 06, 2020

  • Doximity launched Doximity Dialer Video, a telehealth app that enables doctors to video call their patients on any smartphone.

  • Doximity's telehealth solution is HIPAA-secure and doesn't require any extra apps or sign up for software.

  • Doximity Dialer is the company's secure voice calling feature that enables doctors to call patients using their cell phone while setting the caller ID to their hospital or office line.


Professional medical network Doximity is expanding into the telemedicine market.

The company launched Doximity Dialer Video, a telehealth app that enables doctors to video call their patients on any smartphone.

Doximity's telehealth solution is HIPAA-secure and doesn't require patients or doctors to download any extra apps or sign up for software, the company said.

The company has seen a huge spike in engagement on its platform since the onset of the COVID-19 pandemic, said Amit Phull, M.D., Doximity's vice president of strategy and insights.


Doximity was built from the ground up with security and privacy as the top priority, Calls made through Dialer Video are HIPAA-compliant, encrypted, and easy to use. It also works with any health system’s existing suite of telemedicine technologies. For the patient, it works with any smartphone and there are no extra downloads or sign-in required. Doctors can just send a link and connect with their patients instantly.

- Amit Phull, M.D., Doximity's vice president of strategy and insights.

oximity Dialer is the company's secure voice calling feature that enables doctors to call patients using their cell phone while setting the caller ID to their hospital or office line.

"Doctors are relying on Doximity more than ever during this critical time to be efficient, stay up to date with the latest news and research, and to connect with patients safely and securely," Phull said.

As more physicians work from home or turn to virtual care to treat patients, they need tools that work for everyone on their care team and can be rapidly adopted. Close to half of doctors are now using telehealth to treat patients as the COVID-19 pandemic changes practice patterns and how physicians deliver care, according to a survey from the Physicians Foundation.


Read More: UC HOSPITAL SYSTEM TO GRADUALLY RESTART ELECTIVE PROCEDURES CANCELED DUE TO COVID-19


Doximity launched the new telehealth app to meet the needs of physicians for a simple telemedicine tool, the company said.

The demand for telehealth solutions has soared during the pandemic, and the field is now crowded with major industry players like Teladoc and Amwell and new telemedicine solutions that have been released during the pandemic.

Federal health regulators also have waived some restrictions to enable doctors to use consumer-facing tools like Skype and Zoom.

But many mainstream platforms are not HIPAA-compliant and are challenging for patients and their doctors to use, Phull said.

"Other tools proved to be insecure and represented a risk to patient privacy. We’re always asking our physician members for feedback on how we can better serve their clinical needs. Our members told us they wanted an easy-to-use telemedicine tool—something that was secure and protected their privacy, and that of their patients. They also wanted a tool that was simple for patients to use," he said.

About 70% of U.S. physicians already use the Doximity platform every day, according to the company.


Doximity was built from the ground up with security and privacy as the top priority, Calls made through Dialer Video are HIPAA-compliant, encrypted, and easy to use. It also works with any health system’s existing suite of telemedicine technologies. For the patient, it works with any smartphone and there are no extra downloads or sign-in required. Doctors can just send a link and connect with their patients instantly.

- Amit Phull, M.D., Doximity's vice president of strategy and insights.


The Doximity Dialer Video tool includes Custom CallerID which enables physicians to set the CallerID to their hospital or office line and integrates with Epic Haiku, the health IT vendor's mobile electronic health record (EHR) app. 

The platform also complies with the Health Insurance Portability and Accessibility Act (HIPAA) requirements as patient calls are encrypted, kept private, and never recorded, the company said.


Read More: CHANGE HEALTHCARE BUYS BACK PHARMACY UNIT FOR $213M, SELLS ANALYTICS DIVISION TO KAUFMAN HALL
 

Munir Janmohamed, M.D., medical director of advanced heart failure at Dignity Health Sacramento, said physicians need efficient telemedicine tools to do virtual visits from their smartphones.

"It’s reliable, secure and a very simple solution for my patients. It’s incredibly helpful to be able to see them through a video call. This is reassuring for patients and helps me make a better clinical assessment of how they’re doing," Jonmohamed said in a statement.

In response to the COVID-19 crisis, Dialer Video is available for free through January 2021.
 

About Doximity

Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest medical professional network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health.

Spotlight

In this clip from the Women in Health IT roundtable discussion at HIMSS16, Susan Heichert and Dana Alexander talk about efforts they have made toward increasing the number of women in leadership positions in health IT.


Other News
FUTURE OF HEALTHCARE

Dalrada Accelerates Its National Healthcare Model With Acquisition of Watson Rx Solutions

Dalrada Corporation | June 09, 2022

Dalrada Corporation announced that it had acquired the pharmacy, Watson Rx Solutions, Inc. The move highlights Dalrada’s aggressive growth plans within the healthcare sector and paves the way for a total end-to-end total healthcare solution. Adding the 10-year-old pharmacy to Dalrada Health’s comprehensive model expands the subsidiary’s synergies with potential opportunities across its products and services portfolio and offers another solution to meet patient requirements. Dalrada envisions a comprehensive healthcare solution for all Dalrada Health clients with unique offerings that will now include: a pharmacy to facilitate prescription processing, physicians and clinicians at treatment clinics, expanding into telemedicine, engagement of Dalrada-owned testing facilities and laboratories, and utilization of Company-specific technologies to facilitate immediate growth of the business. “Watson Rx has a long history of providing excellent pharmacy services. This acquisition allows Dalrada to expand its healthcare footprint and continue to build a total health management solution on an already successful turnkey operation. As a result, the Company will be able to successfully address the health needs of even more patients.” CEO and Founder, Brian Bonar Through comprehensive prescription management, education, nursing, and total health management, Watson Rx Solutions' leadership team holds more than six decades of combined experience in various complex pharmacy disease states and retail services, always putting patients first. Dalrada plans on entering the pharmaceutical space with an accelerated strategic plan to leverage the Company’s existing capabilities. Research reveals that the U.S. online and mail-order sales of drugs, health, and beauty aids were valued at 75.5 billion USD in 2020. Additionally, E-commerce pharmaceutical sales and beauty aids increased from 51.7 billion USD the year prior. Online, E-commerce, and mail-order sales increased from around 31 to 38 percent during the same period. Pharmacy and drug store sales reached 300 billion USD in 2020, with over-the-counter (OTC) medication accounting for over 36 billion USD in sales during the same year, the highest-selling year to date for the OTC segment. Dalrada and its subsidiaries provide value by making timely and impactful products and services available within health, technology, and clean energy markets. About Dalrada Dalrada Corporation drives innovation that positively impacts people, businesses, and the planet. With subsidiaries that are firmly positioned in the world’s top three-growing industries of healthcare, clean energy, and technology, Dalrada creates solutions that are sustainable, affordable, and accessible. The company works continually to produce disruptive products and services that accelerate positive change for current and future generations. Dalrada’s global solutions directly address climate change, post-pandemic gaps in the healthcare industry, and technology solutions for a new era of human behavior and interaction, ensuring a bright future for the world around us.

Read More

HEALTH TECHNOLOGY

Bright Health Group Expands Executive Team as It Drives Performance in Scaled Businesses

Bright Health Group | May 18, 2022

Bright Health Group, Inc. the first technology-enabled, Fully Aligned System of Care built for healthcare's consumer retail market,announced the expansion of its leadership team with the addition of Michael Carson as Bright HealthCare Chief Executive Officer and Jeff Cook as NeueHealth Chief Executive Officer. These proven leaders, reporting directly to Bright Health Group CEO Mike Mikan, will focus on leading the Company’s two complementary businesses, as Bright HealthCare has gained scale, and NeueHealth emerges as a differentiated market player. Carson will lead the Bright HealthCare business, which has reached scale, and will focus on driving core operational excellence, innovative consumer product and network solutions and profitable, sustainable growth. Carson brings deep experience across the payer and provider space, along with a passion for integrated and transformative healthcare innovation that drives better healthcare outcomes, experiences, and value. Most recently, Carson served as Chief Executive Officer of CareAbout, a multi-market, value-based primary and multi-specialty care start-up, and as President and Chief Executive Officer of Harvard Pilgrim Health Care, a leading not-for-profit health services company. Previously, Carson held leadership positions at Anthem, AmeriGroup, Blue Cross Blue Shield plans, and ConcertoHealth. Cook will lead NeueHealth, Bright Health Group’s personalized care delivery business, which has emerged as a differentiated market player. He will continue to grow and develop our Integrated Systems of Care. Throughout his career, Cook has consistently led initiatives that are at the forefront of value-based care and consumer-driven healthcare. Previously, Cook served as national Vice President of CVS Health HUBs, CVS’ suite of HUB clinical services. Prior to that, Cook served as the South Central Regional President of CVS Health/Aetna and held various leadership positions at Ascension Health and UnitedHealthcare. “Michael and Jeff both bring strong expertise in their respective domains, and most importantly, have a passion for and expertise in fully aligned, value-based care. As we embark on this next phase of Bright Health Group’s journey, we are excited to have these two phenomenal leaders join our already deep bench of talent within Bright HealthCare and NeueHealth.” Mike Mikan, President and CEO, Bright Health Group Sam Srivastava, current CEO of NeueHealth, will serve as a strategic advisor through the end of May to ensure a smooth transition. Jay Matushak, current Interim CEO of Bright HealthCare, will be returning to his previous role as CFO of Bright HealthCare, while taking on an expanded set of responsibilities. Said Mikan, “We want to thank Sam for his many contributions to Bright Health Group and Jay for stepping up to lead Bright HealthCare in the interim. Jay has done a terrific job progressing Bright HealthCare and we look forward to him partnering with Michael as they continue the build on our platform for change in healthcare.” About Bright Health Group Bright Health Group is the first technology-enabled, Fully Aligned System of Care built for healthcare's consumer retail market. Our differentiated approach aligns care delivery with the financing of care to drive better outcomes, lower costs, and enhance the consumer experience. We have two market-facing businesses: NeueHealth and Bright HealthCare. NeueHealth provides care delivery and value-based enablement services to over 500,000 value-based patients through our owned and affiliated clinics. Bright HealthCare offers Commercial and Medicare health plan products to over 1.1 million consumers across the nation. We believe everyone should have access to personal, affordable, and high-quality healthcare. Our mission is to Make healthcare right. Together.

Read More

MEDICAL DEVICES

MedTech Company STENTiT Raises €1.8 million in Seed Round

STENTiT | April 25, 2022

STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for the treatment of cardiovascular diseases, has closed a €1.8 million seed investment round. The funding facilitates further pre-clinical development and batch production of a regenerative stent (see video) for peripheral indications. The investment was made by Dutch investors NextGen Ventures, Brabant Development Agency and the Ten Cate Investment Company. STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions by developing first-of-its-kind endovascular implants with regenerative capacity. Using a catheter-based approach, these devices provide the ability to restore arteries without the need for an invasive surgical intervention. The aim is to ultimately restore the affected blood vessel from the inside out to provide a lifelong solution. As a first target indication, the company wants to improve the treatment of critical limb ischemia. This progressive form of peripheral artery disease affects almost 5 million people in the EU and the US in which the blood flow to the foot is severely being compromised. Unfortunately, current treatment options are ineffective, resulting in amputation within 6 months in 40% of these patients. With the regenerative stent, blood flow to the foot will be maintained by securing vascular patency using temporary mechanical support and improving long-term efficacy by inducing vascular repair, thereby preventing thousands of amputations each year. "We are excited to receive the support of these esteemed Dutch early-stage investors. This financing round validates our vision to bring a novel class of implants that can rebuild the affected blood vessels. We are looking forward taking the next steps getting our regenerative stents ready for clinical trials. With our first product, we aim to treat millions of patients suffering from peripheral artery diseases, and save their limbs from amputation." Bart Sanders, CEO of STENTiT About STENTiT STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants. These bioresorbable devices trigger a natural healing response by the circulating blood cells, in which the implant is being replaced by new vascular tissue to restore the artery from the inside-out. Since the establishment of the company, STENTiT has received broad international recognition and awards for its high-potential approach, covering world leading stages. As the company is currently going through the next translational phases, STENTiT is on its way to fulfill its ambition to become the new standard in endovascular treatment, providing a life-changing solution for millions of cardiovascular patients around the world.

Read More

DIGITAL HEALTHCARE

Jumio Accelerates Digital Transformation in Middle East with KYX Platform

Jumio | March 21, 2022

Jumio, the leading provider of AI-powered end-to-end identity orchestration, eKYC and AML solutions, announced the launch of a Middle Eastern solutions portfolio and the appointment of Arshad Sheikh as its first sales leader for the Middle East, Turkey and North Africa region. This expansion builds on Jumio’s long-standing presence in the Middle East and its ongoing commitment to revolutionize banking for a growing number of customers in the region. A recent forecast from the International Data Corporation states that digital transformation efforts in the Middle East, Turkey and Africa are set to top $58 billion in 2025, accounting for 40% of all information communication technology investments made that year. Additionally, McKinsey & Company found that 83% percent of payments practitioners operating in the Middle East and Africa believe digitizing the customer journey is the most important way to remain relevant in an evolving market. With the Jumio KYX Platform, businesses from banking and financial services to government, healthcare and travel sectors can tap into services that accelerate digital transformation without sacrificing security and convenience. The KYX Platform leverages AI, biometrics, machine learning and certified liveness detection to help enterprises rapidly convert customers, stop fraudsters and maintain KYC and AML compliance. The key features and advantages of the platform extend an organization’s ability to monitor customer behavior from the initial point of account creation through the full lifecycle of customer interactions. Based in Dubai, Sheikh will focus on expanding the company’s client base, growing relationships with existing clients and cultivating a sustainable partner network. Sheikh has more than 20 years of sales, business development and cybersecurity experience in the Middle East. Before joining Jumio, Sheikh worked at Carbon Black/VMWare, Barracuda Networks, Informatica, TrendMicro and Mindware. “We are proud to continue growing in the METNA region in order to better serve the needs of our local customers and partners and to expand our global footprint so organizations can truly know their end users, no matter where in the world they are. Most industries in the region have been swept up in the need to digitally transform their businesses. Jumio’s end-to-end orchestration platform, aided by our extensive partner network, will massively simplify the journey and deliver successful business outcomes across all key industry sectors.” Dean Hickman-Smith, Jumio chief revenue officer For a live demonstration of the Jumio KYX Platform, visit Jumio at booth A34 during GISEC Global, which takes place this week in Dubai. About Jumio When identity matters, trust Jumio. Jumio’s mission is to make the internet a safer place by protecting the ecosystems of businesses through a unified, end-to-end identity verification, eKYC and AML platform. The Jumio KYX Platform offers a range of identity proofing and AML services to accurately establish, maintain and reassert trust from account opening to ongoing transaction monitoring. Leveraging advanced technology including AI, biometrics, machine learning, liveness detection and automation, Jumio helps organizations fight fraud and financial crime, onboard good customers faster and meet regulatory compliance including KYC, AML and GDPR. Jumio has carried out more than 500 million verifications spanning over 200 countries and territories from real-time web and mobile transactions. Based in Palo Alto, Jumio operates globally with offices in North America, Latin America, Europe and Asia Pacific and has been the recipient of numerous awards for innovation. Jumio is backed by Centana Growth Partners, Great Hill Partners and Millennium Technology Value Partners.

Read More

Spotlight

In this clip from the Women in Health IT roundtable discussion at HIMSS16, Susan Heichert and Dana Alexander talk about efforts they have made toward increasing the number of women in leadership positions in health IT.

Resources